• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内氧化脂蛋白的结构与动力学:高密度脂蛋白的作用

Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein.

作者信息

Itabe Hiroyuki, Sawada Naoko, Makiyama Tomohiko, Obama Takashi

机构信息

Division of Biological Chemistry, Department of Pharmaceutical Sciences, School of Pharmacy, Showa University, 1-5-8 Hatanodai, Tokyo 142-8555, Japan.

出版信息

Biomedicines. 2021 Jun 8;9(6):655. doi: 10.3390/biomedicines9060655.

DOI:10.3390/biomedicines9060655
PMID:34201176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8229488/
Abstract

Oxidative modification of lipoproteins is implicated in the occurrence and development of atherosclerotic lesions. Earlier studies have elucidated on the mechanisms of foam cell formation and lipid accumulation in these lesions, which is mediated by scavenger receptor-mediated endocytosis of oxidized low-density lipoprotein (oxLDL). Mounting clinical evidence has supported the involvement of oxLDL in cardiovascular diseases. High-density lipoprotein (HDL) is known as anti-atherogenic; however, recent studies have shown circulating oxidized HDL (oxHDL) is related to cardiovascular diseases. A modified structure of oxLDL, which was increased in the plasma of patients with acute myocardial infarction, was characterized. It had two unique features: (1) a fraction of oxLDL accompanied oxHDL, and (2) apoA1 was heavily modified, while modification of apoB, and the accumulation of oxidized phosphatidylcholine (oxPC) and lysophosphatidylcholine (lysoPC) was less pronounced. When LDL and HDL were present at the same time, oxidized lipoproteins actively interacted with each other, and oxPC and lysoPC were transferred to another lipoprotein particle and enzymatically metabolized rapidly. This brief review provides a novel view on the dynamics of oxLDL and oxHDL in circulation.

摘要

脂蛋白的氧化修饰与动脉粥样硬化病变的发生和发展有关。早期研究阐明了这些病变中泡沫细胞形成和脂质积累的机制,这是由清道夫受体介导的氧化低密度脂蛋白(oxLDL)的内吞作用介导的。越来越多的临床证据支持oxLDL参与心血管疾病。高密度脂蛋白(HDL)被认为具有抗动脉粥样硬化作用;然而,最近的研究表明循环氧化HDL(oxHDL)与心血管疾病有关。对急性心肌梗死患者血浆中增加的oxLDL的修饰结构进行了表征。它有两个独特的特征:(1)一部分oxLDL与oxHDL相伴,(2)载脂蛋白A1被大量修饰,而载脂蛋白B的修饰以及氧化磷脂酰胆碱(oxPC)和溶血磷脂酰胆碱(lysoPC)的积累则不太明显。当LDL和HDL同时存在时,氧化脂蛋白会积极地相互作用,oxPC和lysoPC会转移到另一个脂蛋白颗粒上并迅速进行酶促代谢。这篇简短的综述提供了关于循环中oxLDL和oxHDL动态变化的新观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/9b1b7f877e23/biomedicines-09-00655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/970939fe59ed/biomedicines-09-00655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/8b4ca1e415f5/biomedicines-09-00655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/177c07cf148a/biomedicines-09-00655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/9b1b7f877e23/biomedicines-09-00655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/970939fe59ed/biomedicines-09-00655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/8b4ca1e415f5/biomedicines-09-00655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/177c07cf148a/biomedicines-09-00655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc5/8229488/9b1b7f877e23/biomedicines-09-00655-g004.jpg

相似文献

1
Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein.体内氧化脂蛋白的结构与动力学:高密度脂蛋白的作用
Biomedicines. 2021 Jun 8;9(6):655. doi: 10.3390/biomedicines9060655.
2
Transfer and Enzyme-Mediated Metabolism of Oxidized Phosphatidylcholine and Lysophosphatidylcholine between Low- and High-Density Lipoproteins.氧化磷脂酰胆碱和溶血磷脂酰胆碱在低密度脂蛋白和高密度脂蛋白之间的转运及酶介导代谢
Antioxidants (Basel). 2020 Oct 26;9(11):1045. doi: 10.3390/antiox9111045.
3
Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.在急性心肌梗死患者中增加的循环氧化 LDL 伴随着大量修饰的 HDL。
J Lipid Res. 2020 Jun;61(6):816-829. doi: 10.1194/jlr.RA119000312. Epub 2020 Apr 14.
4
The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation.体内氧化脂蛋白:其在人体循环中的多样性和行为。
Int J Mol Sci. 2023 Mar 17;24(6):5747. doi: 10.3390/ijms24065747.
5
Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.巨噬细胞中氧化磷脂酰胆碱-载脂蛋白B复合物的溶酶体积累:氧化低密度脂蛋白的细胞内命运
Biochim Biophys Acta. 2000 Sep 27;1487(2-3):233-45. doi: 10.1016/s1388-1981(00)00098-6.
6
Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.时间进程-在低密度脂蛋白氧化修饰过程中磷脂酰胆碱谱的变化。
Lipids Health Dis. 2014 Mar 14;13:48. doi: 10.1186/1476-511X-13-48.
7
Oxidized low-density lipoproteins: what is understood and what remains to be clarified.氧化型低密度脂蛋白:已知内容与待阐明之处
Biol Pharm Bull. 2003 Jan;26(1):1-9. doi: 10.1248/bpb.26.1.
8
[Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].[动脉粥样硬化与使用单克隆抗体对氧化型低密度脂蛋白的灵敏测定]
Yakugaku Zasshi. 2002 Oct;122(10):745-53. doi: 10.1248/yakushi.122.745.
9
[Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].[氧化型脂蛋白的前沿领域:氧化型脂蛋白在动脉粥样硬化形成及心血管疾病风险中的作用]
Rinsho Byori. 2010 Jun;58(6):622-30.
10
Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism.氧化型高密度脂蛋白诱导细胞毒性作用:对动脉粥样硬化发病机制的启示。
J Biochem Mol Toxicol. 2014 Nov;28(11):481-9. doi: 10.1002/jbt.21588. Epub 2014 Jul 11.

引用本文的文献

1
Oxymatrine impedes Alzheimer's progression via the attenuation of hypercholesterolemia and fibrosis.氧化苦参碱通过减轻高胆固醇血症和纤维化来延缓阿尔茨海默病的进展。
Metab Brain Dis. 2025 Apr 17;40(5):187. doi: 10.1007/s11011-025-01606-w.
2
Atherogenic circulating lipoproteins in ischemic stroke.缺血性卒中中的致动脉粥样硬化循环脂蛋白
Front Cardiovasc Med. 2024 Dec 6;11:1470364. doi: 10.3389/fcvm.2024.1470364. eCollection 2024.
3
Oxidized Low-Density Lipoprotein and Its Role in Immunometabolism.氧化型低密度脂蛋白及其在免疫代谢中的作用。

本文引用的文献

1
Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases.中性粒细胞作为修饰性低密度脂蛋白的新靶点和心血管疾病的加速器。
Int J Mol Sci. 2020 Nov 5;21(21):8312. doi: 10.3390/ijms21218312.
2
Transfer and Enzyme-Mediated Metabolism of Oxidized Phosphatidylcholine and Lysophosphatidylcholine between Low- and High-Density Lipoproteins.氧化磷脂酰胆碱和溶血磷脂酰胆碱在低密度脂蛋白和高密度脂蛋白之间的转运及酶介导代谢
Antioxidants (Basel). 2020 Oct 26;9(11):1045. doi: 10.3390/antiox9111045.
3
Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein.
Int J Mol Sci. 2024 Oct 23;25(21):11386. doi: 10.3390/ijms252111386.
4
The role of NETosis in heart failure.中性粒细胞胞外诱捕网/NETosis 在心力衰竭中的作用。
Heart Fail Rev. 2024 Sep;29(5):1097-1106. doi: 10.1007/s10741-024-10421-x. Epub 2024 Jul 29.
5
Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process.活性氧、氧化型低密度脂蛋白和凝集素样氧化型低密度脂蛋白受体1:动脉粥样硬化进程中的恶性循环。
Antioxidants (Basel). 2024 May 9;13(5):583. doi: 10.3390/antiox13050583.
6
Lipid-Derived Biomarkers as Therapeutic Targets for Chronic Coronary Syndrome and Ischemic Stroke: An Updated Narrative Review.脂质衍生生物标志物作为慢性冠状动脉综合征和缺血性中风的治疗靶点:最新叙述性综述
Medicina (Kaunas). 2024 Mar 29;60(4):561. doi: 10.3390/medicina60040561.
7
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration.从失衡到损伤:活性氧在氧化应激诱导的疾病中的核心作用及治疗探索
Front Pharmacol. 2023 Oct 18;14:1269581. doi: 10.3389/fphar.2023.1269581. eCollection 2023.
8
Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data.基于实验室指标和临床数据分析建立视神经脊髓炎谱系疾病综合诊断模型。
Neurol Sci. 2023 Oct;44(10):3647-3657. doi: 10.1007/s10072-023-06853-2. Epub 2023 May 16.
9
The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation.体内氧化脂蛋白:其在人体循环中的多样性和行为。
Int J Mol Sci. 2023 Mar 17;24(6):5747. doi: 10.3390/ijms24065747.
10
High-Density Lipoprotein Suppresses Neutrophil Extracellular Traps Enhanced by Oxidized Low-Density Lipoprotein or Oxidized Phospholipids.高密度脂蛋白抑制氧化型低密度脂蛋白或氧化型磷脂增强的中性粒细胞胞外诱捕网。
Int J Mol Sci. 2022 Nov 13;23(22):13992. doi: 10.3390/ijms232213992.
氧化型高密度脂蛋白酶联免疫吸附测定法的研发与临床应用
J Atheroscler Thromb. 2021 Jul 1;28(7):703-715. doi: 10.5551/jat.56887. Epub 2020 Oct 17.
4
Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.在急性心肌梗死患者中增加的循环氧化 LDL 伴随着大量修饰的 HDL。
J Lipid Res. 2020 Jun;61(6):816-829. doi: 10.1194/jlr.RA119000312. Epub 2020 Apr 14.
5
Intracellular transports and atherogenesis.细胞内运输与动脉粥样硬化形成。
Front Biosci (Landmark Ed). 2020 Mar 1;25(7):1230-1258. doi: 10.2741/4854.
6
Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization, detection, and functional implications.氧化磷脂对高密度脂蛋白载脂蛋白的交联修饰:结构特征、检测及功能意义。
J Biol Chem. 2020 Feb 14;295(7):1973-1984. doi: 10.1074/jbc.RA119.008445. Epub 2020 Jan 6.
7
Modification of HDL by reactive aldehydes alters select cardioprotective functions of HDL in macrophages.反应性醛修饰高密度脂蛋白会改变高密度脂蛋白在巨噬细胞中的某些心脏保护功能。
FEBS J. 2020 Feb;287(4):695-707. doi: 10.1111/febs.15034. Epub 2019 Aug 14.
8
Oxylipin profile of human low-density lipoprotein is dependent on its extent of oxidation.人低密度脂蛋白的氧化脂质谱与其氧化程度有关。
Atherosclerosis. 2019 Sep;288:101-111. doi: 10.1016/j.atherosclerosis.2019.07.018. Epub 2019 Jul 18.
9
Increased Oxidized High-Density Lipoprotein/High-Density Lipoprotein-Cholesterol Ratio as a Potential Indicator of Disturbed Metabolic Health in Overweight and Obese Individuals.氧化型高密度脂蛋白/高密度脂蛋白胆固醇比值升高作为超重和肥胖个体代谢健康紊乱的潜在指标。
Lab Med. 2020 Jan 2;51(1):24-33. doi: 10.1093/labmed/lmz017.
10
Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study.高密度脂蛋白氧化减少与冠状动脉钙化进展缓慢有关:一项前瞻性多中心研究的亚分析。
Atherosclerosis. 2019 Apr;283:1-6. doi: 10.1016/j.atherosclerosis.2019.01.032. Epub 2019 Feb 1.